Replies to post #3962 on Bitcoin Generation Inc. (BTGN)

[beentomyrasite]

sweet numbers!!

wrong? spend your day twisting words or whatever

did you see my Projection at all: FIVE PERCENT

naturally that is not everyone

yet, MOST will likely get tested anyway, and this projection is likely short term low milestone...



here they are again!!!!

If InoLife captures JUST 5% of the existing market share for Plavix and the 6M new prescriptions in the next 3 months, this is what the stock price would be at $250 cost:

$5.56

That's EBITDA, etc. But also without a multiple.

Lop off 40% for margin of error, and it's $3.34

Imagine if 50% market share, or 80%


legend:

5%Mkt share * 9M new Plavix users 3 months = 450,000

5%Mkt share * 48M Plavix users = 2.4M

128 OS

$250 cost

[tob999]

wrong again... the test isn't for everyone.

only those at risks due to clotting. the tests are to find out how close they are to a certain point so the doctor knows whether to increase or decrease the dosage.

Duh, surely those at risk due to clotting can only find that out with this test?! Means everyone who is to go on Plavix will need the test in order to see if it is right for them. 12% cannot use Plavix as they fail the test. Got it?

[shappy]

The test is for every user new and existing. I believe its 14% of the users should not be taking plavix. This test will show this information.